Larry Wood - Jun 1, 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, TAVR
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
Jun 1, 2022
Transactions value $
-$461,909
Form type
4
Date filed
6/1/2022, 06:04 PM
Previous filing
May 17, 2022
Next filing
Jul 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $266K +7.24K +3.58% $36.75 209K Jun 1, 2022 Direct F1, F2
transaction EW Common Stock Sale -$279K -2.76K -1.32% $101.09 207K Jun 1, 2022 Direct F1, F3
transaction EW Common Stock Sale -$449K -4.48K -2.17% $100.19 202K Jun 1, 2022 Direct F1, F4
holding EW Common Stock 496 Jun 1, 2022 401(k) F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -7.24K -14.29% $0.00 43.4K Jun 1, 2022 Common Stock 7.24K $36.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021.
F2 Represents shares transferred to the reporting person's ex-spouse pursuant to a divorce judgement. The securities owned by the ex-spouse are not beneficially owned by the reporting person.
F3 This transaction was executed in multiple trades at prices ranging from $100.78 to $101.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $99.76 to $100.75. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F5 Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.